Latest Breaking News On - Vincerx pharma inc - Page 1 : vimarsana.com

Vincerx Pharma, Inc (NASDAQ:VINC) Short Interest Down 44 9% in May

Vincerx Pharma, Inc. (NASDAQ:VINC – Get Free Report) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 567,500 shares, a decrease of 44.9% from the April 30th total of 1,030,000 shares. Based on an average trading volume of 927,300 shares, the short-interest ratio is presently 0.6 […]

United statesVincerx pharmaCantor fitzgeraldVincerx pharma company profileExchange commissionVincerx pharma incVanguard group incGet free reportFree reportVincerx pharma daily

Vincerx Pharma, Inc (NASDAQ:VINC) Sees Large Decline in Short Interest

Vincerx Pharma, Inc. (NASDAQ:VINC – Get Free Report) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 567,500 shares, a decline of 44.9% from the April 30th total of 1,030,000 shares. Based on an average daily volume of 927,300 shares, […]

United statesVincerx pharmaExchange commissionVanguard group incCantor fitzgeraldVincerx pharma incGet free reportFree reportVincerx pharma daily

Vincerx Pharma (NASDAQ:VINC) Announces Earnings Results

Vincerx Pharma (NASDAQ:VINC) Announces Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesVincerx pharmaVanguard group incExchange commissionCantor fitzgeraldVincerx pharma incGet free reportFree reportVincerx pharma daily

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPalo altoAhmed hamdyTotyana simienVincerx celltrapperGabriela jairalaVincerx versaptxVincerx pharma incVincerxpharma incAmerican association for cancer researchNational institutes of healthSecurities exchangeUniversity of calgaryPediatric oncology experimental therapeutics investigator consortiumExchange commissionPharma reports first quarter

Immune Therapeutics (OTCMKTS:IMUN) vs Vincerx Pharma (NASDAQ:VINC) Critical Analysis

Immune Therapeutics (OTCMKTS:IMUN – Get Free Report) and Vincerx Pharma (NASDAQ:VINC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, valuation, dividends and risk. Earnings & Valuation This table compares Immune […]

United statesPalo altoWinter parkVincerx pharmaBiotech incVincerx pharma incTherapeutics incAimmune therapeuticsGet free reportGiven vincerx pharmaImmune therapeutics dailyOtcmkts imunStock comparisonStock analysis